文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

住院期间急性肾损伤后的长期结局:匹配对照研究的系统评价与Meta分析

Long-Term Outcomes After Acute Kidney Injury During Hospitalization: A Systematic Review and Meta-Analysis of Matched Controls Studies.
PubMed 文献 · Crit Care Med · 2025-11-17
一句话结论住院期间发生急性肾损伤并存活出院的患者,与无急性肾损伤的对照相比,长期死亡、透析和慢性肾脏病风险均显著增加。

该系统评价与Meta分析纳入14项匹配对照研究,共1,058,109例匹配患者,中位随访3年,比较住院期间发生急性肾损伤并存活出院者与无急性肾损伤对照的长期结局。急性肾损伤组长期死亡率26.4% vs 对照组17.6%(RR 1.42,95%CI 1.13-1.78,p=0.002),透析风险4.5% vs 2.0%(RR 2.48,95%CI 1.79-3.43,p<0.001),慢性肾脏病风险51.5% vs 37.3%(RR 1.71,95%CI 1.33-2.19,p<0.001)。提示急性肾损伤存活出院患者需长期随访肾功能与透析风险。

要点

  • 急性肾损伤存活出院者长期死亡风险较无急性肾损伤对照升高:26.4% vs 17.6%,RR 1.42(95%CI 1.13-1.78)。
  • 急性肾损伤存活出院者后续透析风险较对照升高:4.5% vs 2.0%,RR 2.48(95%CI 1.79-3.43)。
  • 急性肾损伤存活出院者慢性肾脏病风险较对照升高:51.5% vs 37.3%,RR 1.71(95%CI 1.33-2.19)。
  • 该系统评价纳入14项匹配对照研究,共1,058,109例匹配患者,中位随访3年。
  • 急性肾损伤存活出院患者长期死亡、透析和慢性肾脏病风险均显著增加。

适用人群与场景

  • 住院期间发生急性肾损伤并存活出院的患者,与无急性肾损伤的对照人群比较。
  • 纳入标准:经历并存活明确急性肾损伤发作、有无急性肾损伤对照组、报告至少一项长期结局(死亡、透析或慢性肾脏病)、随访至少1年。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入14项匹配对照研究,共1,058,109例匹配患者,中位随访3年。
  • 主要结局长期死亡:急性肾损伤组137,506/519,672(26.4%)vs 对照组93,702/530,663(17.6%),RR 1.42(95%CI 1.13-1.78,p=0.002)。
  • 次要结局透析:急性肾损伤组1,928/42,529(4.5%)vs 对照组854/42,529(2.0%),RR 2.48(95%CI 1.79-3.43,p<0.001)。
  • 次要结局慢性肾脏病:急性肾损伤组2,956/5,739(51.5%)vs 对照组2,902/7,781(37.3%),RR 1.71(95%CI 1.33-2.19,p<0.001)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入原始研究为匹配对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对住院期间发生急性肾损伤并存活出院的患者,应认识到其长期死亡、透析和慢性肾脏病风险较无急性肾损伤对照显著增加。
  • 该系统评价结果提示急性肾损伤存活出院患者需要长期随访肾功能和透析风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The impact of acute kidney injury (AKI) on long-term outcomes of hospital survivors is controversial. We conducted a systematic review and meta-analysis of all studies reporting such outcomes in patients with AKI and including a control population.

DATA SOURCES: We included original studies published in peer-reviewed journals that compared long-term outcomes (survival, need for dialysis, chronic kidney disease [CKD]) among hospitalized patients with vs. without AKI.

STUDY SELECTION: Pertinent articles enrolled patients who experienced and survived a defined episode of AKI, included a control group without AKI, and reported at least one long-term outcome (mortality, dialysis, or CKD), with a minimum follow-up of 1 year.

DATA EXTRACTION: Two independent investigators extracted data on study characteristics, patient populations, follow-up duration, and long-term outcomes. Discrepancies were resolved by consensus.

DATA SYNTHESIS: We identified 14 studies for a total of 1,058,109 overall matched patients with a median duration of follow-up of 3 years. Patients who experienced an episode of AKI and survived hospital discharge had a significant increase in long-term mortality at the longest follow-up available for each study (137,506/519,672 [26.4%] vs. 93,702/530,663 [17.6%]; relative risk [RR], 1.42; 95% CI, 1.13-1.78; p = 0.002), compared with controls. They also had a greater risk of receiving dialysis (1,928/42,529 [4.5%] vs. 854/42,529 [2.0%]; RR, 2.48; 95% CI, 1.79-3.43; p < 0.001), and of developing CKD (2,956/5,739 [51.5%] vs. 2,902/7,781 [37.3%]; RR, 1.71; 95% CI, 1.33-2.19; p < 0.001).

CONCLUSIONS: Compared with controls, patients who experienced an episode of AKI and survived to hospital discharge have an increased risk of death, dialysis, and CKD.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Fresilli S, Labanca R, Losiggio R, et al. Long-Term Outcomes After Acute Kidney Injury During Hospitalization: A Systematic Review and Meta-Analysis of Matched Controls Studies. Crit Care Med. 2025. PMID: 41247233. doi:10.1097/CCM.0000000000006953

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。